186 related articles for article (PubMed ID: 35563740)
41. Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.
Horn D; Hess J; Freier K; Hoffmann J; Freudlsperger C
Expert Opin Ther Targets; 2015 Jun; 19(6):795-805. PubMed ID: 25652792
[TBL] [Abstract][Full Text] [Related]
42. Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma.
Kähler J; Hafner S; Popp T; Hermann C; Rump A; Port M; Steinestel K; Eder S
Int J Mol Med; 2020 Nov; 46(5):1733-1742. PubMed ID: 32901844
[TBL] [Abstract][Full Text] [Related]
43. Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells.
Eckers JC; Kalen AL; Sarsour EH; Tompkins VS; Janz S; Son JM; Doskey CM; Buettner GR; Goswami PC
Radiat Res; 2014 Oct; 182(4):420-9. PubMed ID: 25229973
[TBL] [Abstract][Full Text] [Related]
44. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
[TBL] [Abstract][Full Text] [Related]
46. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
[TBL] [Abstract][Full Text] [Related]
48. Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
Routila J; Suvila K; Grénman R; Leivo I; Westermarck J; Ventelä S
BMC Cancer; 2021 Jul; 21(1):868. PubMed ID: 34320941
[TBL] [Abstract][Full Text] [Related]
49. Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis.
Liu J; Ge YY; Zhu HC; Yang X; Cai J; Zhang C; Lu J; Zhan LL; Qin Q; Yang Y; Yang YH; Zhang H; Chen XC; Liu ZM; Ma JX; Cheng HY; Sun XC
Asian Pac J Cancer Prev; 2014; 15(16):6649-55. PubMed ID: 25169503
[TBL] [Abstract][Full Text] [Related]
50. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
[TBL] [Abstract][Full Text] [Related]
51. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
[TBL] [Abstract][Full Text] [Related]
52. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.
Camacho M; Piñeiro Z; Alcolea S; García J; Balart J; Terra X; Avilés-Jurado FX; Soler M; Quer M; León X; Vila L
J Pathol; 2015 Jan; 235(1):125-35. PubMed ID: 25256272
[TBL] [Abstract][Full Text] [Related]
53. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
54. UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis.
Zhou Y; Zhang J; Gong J; Tang X; Zhang C
Aging (Albany NY); 2022 Sep; 14(17):7003-7013. PubMed ID: 36069832
[TBL] [Abstract][Full Text] [Related]
55. Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications.
Perri F; Pacelli R; Della Vittoria Scarpati G; Cella L; Giuliano M; Caponigro F; Pepe S
Head Neck; 2015 May; 37(5):763-70. PubMed ID: 24995469
[TBL] [Abstract][Full Text] [Related]
56. Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer.
Ricco N; Flor A; Wolfgeher D; Efimova EV; Ramamurthy A; Appelbe OK; Brinkman J; Truman AW; Spiotto MT; Kron SJ
Mol Oncol; 2019 Sep; 13(9):1927-1943. PubMed ID: 31225926
[TBL] [Abstract][Full Text] [Related]
57. Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Bucek S; Groselj B; Strojan P; Cemazar M; Sersa G
Radiol Oncol; 2020 Mar; 54(2):168-179. PubMed ID: 32229678
[TBL] [Abstract][Full Text] [Related]
58. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.
Özcan-Wahlbrink M; Schifflers C; Riemer AB
Front Immunol; 2019; 10():2831. PubMed ID: 31849993
[TBL] [Abstract][Full Text] [Related]
59. The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Hagege A; Ambrosetti D; Boyer J; Bozec A; Doyen J; Chamorey E; He X; Bourget I; Rousset J; Saada E; Rastoin O; Parola J; Luciano F; Cao Y; Pagès G; Dufies M
Theranostics; 2021; 11(19):9571-9586. PubMed ID: 34646387
[No Abstract] [Full Text] [Related]
60. HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.
Tong F; Mao X; Zhang S; Xie H; Yan B; Wang B; Sun J; Wei L
Cancer Lett; 2020 May; 478():34-44. PubMed ID: 32120025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
